FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897034732> ?p ?o ?g. }

• W2897034732 endingPage "1081" @default.
• W2897034732 startingPage "1074" @default.
• W2897034732 abstract "Background The real size of the gastro-oesophageal reflux disease (GERD) population not responding to proton pump inhibitor (PPI) therapy has still not been fully elucidated. Causes of PPI refractoriness include incorrect diagnosis and lack of adherence to therapy, in terms of incorrect dosage and timing. Aims To evaluate the prevalence of refractoriness to optimal PPI therapy and the contribution of non-erosive reflux disease (NERD), reflux hypersensitivity, and functional heartburn, to PPI refractoriness. The association of functional GI symptoms in non-responders was evaluated. Methods Frequency and severity of GERD symptoms (heartburn, regurgitation, chest pain), dysphagia, belching, epigastric pain, postprandial distress, irritable bowel syndrome (IBS), globus, and ear nose and throat (ENT) symptoms were evaluated in patients previously classified as non-responders. Patients with at least one of the oesophageal symptoms with a frequency ≥3 /week were treated with esomeprazole 40 mg once daily for 8 weeks and then re-evaluated. Non-responders (patients with oesophageal symptoms ≥3 times per week) underwent 24 hour multichannel intraluminal impedance-pH monitoring. Results Of 573 consecutive patients, 92 with oesophageal symptoms and classified as PPI-refractory underwent the esomeprazole trial; 60 did not respond. IBS, epigastric pain, and post-prandial distress episodes were associated with a poor response on multivariate analysis. NERD, reflux hypersensitivity, and functional heartburn patients constituted 32%, 42%, and 26%, respectively of the PPI-refractory group. Conclusions True refractoriness in patients with GERD symptoms attending a secondary care setting is lower than previously reported. Following a careful history and optimal PPI dosing, the rate of refractoriness was 20%. True NERD constitutes only a third of the PPI-refractory group." @default.
• W2897034732 created "2018-10-26" @default.
• W2897034732 creator A5001468603 @default.
• W2897034732 creator A5001660061 @default.
• W2897034732 creator A5015345512 @default.
• W2897034732 creator A5026825925 @default.
• W2897034732 creator A5038637232 @default.
• W2897034732 creator A5062274908 @default.
• W2897034732 creator A5069628847 @default.
• W2897034732 creator A5079088017 @default.
• W2897034732 creator A5084096786 @default.
• W2897034732 date "2018-10-07" @default.
• W2897034732 modified "2023-10-16" @default.
• W2897034732 title "Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease" @default.
• W2897034732 cites W1506487485 @default.
• W2897034732 cites W1968552480 @default.
• W2897034732 cites W1988774477 @default.
• W2897034732 cites W1995599980 @default.
• W2897034732 cites W1999600314 @default.
• W2897034732 cites W2008373894 @default.
• W2897034732 cites W2016243150 @default.
• W2897034732 cites W2019203561 @default.
• W2897034732 cites W2020778999 @default.
• W2897034732 cites W2033585031 @default.
• W2897034732 cites W2035944251 @default.
• W2897034732 cites W2036589016 @default.
• W2897034732 cites W2048805550 @default.
• W2897034732 cites W2055836266 @default.
• W2897034732 cites W2063591331 @default.
• W2897034732 cites W2071049245 @default.
• W2897034732 cites W2075008048 @default.
• W2897034732 cites W2084264352 @default.
• W2897034732 cites W2092148076 @default.
• W2897034732 cites W2114442699 @default.
• W2897034732 cites W2118651616 @default.
• W2897034732 cites W2118748578 @default.
• W2897034732 cites W2127647682 @default.
• W2897034732 cites W2129791755 @default.
• W2897034732 cites W2137678441 @default.
• W2897034732 cites W2147038141 @default.
• W2897034732 cites W2148800153 @default.
• W2897034732 cites W2157778300 @default.
• W2897034732 cites W2158690779 @default.
• W2897034732 cites W2159657819 @default.
• W2897034732 cites W2345880044 @default.
• W2897034732 cites W2601059298 @default.
• W2897034732 cites W2785608288 @default.
• W2897034732 cites W2786257226 @default.
• W2897034732 cites W2793306317 @default.
• W2897034732 cites W1964426919 @default.
• W2897034732 doi "https://doi.org/10.1111/apt.14986" @default.
• W2897034732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30294924" @default.
• W2897034732 hasPublicationYear "2018" @default.
• W2897034732 type Work @default.
• W2897034732 sameAs 2897034732 @default.
• W2897034732 citedByCount "30" @default.
• W2897034732 countsByYear W28970347322018 @default.
• W2897034732 countsByYear W28970347322019 @default.
• W2897034732 countsByYear W28970347322020 @default.
• W2897034732 countsByYear W28970347322021 @default.
• W2897034732 countsByYear W28970347322022 @default.
• W2897034732 countsByYear W28970347322023 @default.
• W2897034732 crossrefType "journal-article" @default.
• W2897034732 hasAuthorship W2897034732A5001468603 @default.
• W2897034732 hasAuthorship W2897034732A5001660061 @default.
• W2897034732 hasAuthorship W2897034732A5015345512 @default.
• W2897034732 hasAuthorship W2897034732A5026825925 @default.
• W2897034732 hasAuthorship W2897034732A5038637232 @default.
• W2897034732 hasAuthorship W2897034732A5062274908 @default.
• W2897034732 hasAuthorship W2897034732A5069628847 @default.
• W2897034732 hasAuthorship W2897034732A5079088017 @default.
• W2897034732 hasAuthorship W2897034732A5084096786 @default.
• W2897034732 hasBestOaLocation W28970347321 @default.
• W2897034732 hasConcept C121332964 @default.
• W2897034732 hasConcept C126322002 @default.
• W2897034732 hasConcept C141071460 @default.
• W2897034732 hasConcept C142424586 @default.
• W2897034732 hasConcept C2776462128 @default.
• W2897034732 hasConcept C2777014526 @default.
• W2897034732 hasConcept C2777683962 @default.
• W2897034732 hasConcept C2778204628 @default.
• W2897034732 hasConcept C2778271842 @default.
• W2897034732 hasConcept C2778704086 @default.
• W2897034732 hasConcept C2779134260 @default.
• W2897034732 hasConcept C2780168065 @default.
• W2897034732 hasConcept C2780596822 @default.
• W2897034732 hasConcept C2780852908 @default.
• W2897034732 hasConcept C2781025758 @default.
• W2897034732 hasConcept C2991960855 @default.
• W2897034732 hasConcept C43270747 @default.
• W2897034732 hasConcept C71924100 @default.
• W2897034732 hasConcept C87355193 @default.
• W2897034732 hasConcept C90924648 @default.
• W2897034732 hasConceptScore W2897034732C121332964 @default.
• W2897034732 hasConceptScore W2897034732C126322002 @default.
• W2897034732 hasConceptScore W2897034732C141071460 @default.
• W2897034732 hasConceptScore W2897034732C142424586 @default.
• W2897034732 hasConceptScore W2897034732C2776462128 @default.

• next